Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saccharomyces Boulardii for Prevention of Antibiotic-Associated Diarrhea in Children on Co-amoxiclav
NCT07785206Not yet recruiting
- Sponsor
- University of Child Health Sciences and Children's Hospital, Lahore
- Start
- Sep 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Randomised, single-blind trial of saccharomyces boulardii in antibiotic-associated diarrhea (AAD) (2 arms), sponsored by University of Child Health Sciences and Children's Hospital, Lahore. Primary endpoint: Incidence of Antibiotic-Associated Diarrhea at Day 14. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
saccharomyces boulardii
03
Conditions
antibiotic-associated diarrhea (AAD)
Beyond the preview
Go deeper on NCT07785206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07785206.